⌘K

Login Start Free

Home/Filings/4/0000899243-22-018135

4//SEC Filing

Maimon Yossi 4

Accession 0000899243-22-018135

CIK 0001797336other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:10 PM ET

Size

4.9 KB

Accession

0000899243-22-018135

Insider Transaction Report

Form 4

Period: 2022-05-16

Ayala Pharmaceuticals, Inc.AYLA

CFO

Transactions

Award
Common Stock
2022-05-16+50,000→ 69,872 total

Footnotes (1)

[F1]Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ayala Pharmaceuticals, Inc.

CIK 0001797336

Entity typeother

Related Parties

1

filerCIK 0001385115

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 4:10 PM ET
Size: 4.9 KB

View on SEC.gov